National Institutes of Health's Pharmaceutical Portfolio

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Quiver Bioscience develops medicines for brain disorders using human disease models and advanced AI technologies.

Psilera is a biotechnology company that develops treatments for neurological and psychiatric disorders.

Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.

South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .

Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients

eXoZymes specializes in enzyme design and the development of cell-free enzymatic pathways.

Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.

Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.

Nuravax develops and researches on vaccines, preventive solutions and treatment for neurodegenerative disorders.